rivastigmine 1.5 mg capsule

About rivastigmine 1.5 mg capsule

Rivastigmine 1.5 mg capsule, marketed as PYRITIGMIN RIVA 1.5, is a prescription medication primarily used for the treatment of mild to moderate dementia associated with Alzheimers disease and Parkinsons disease. It belongs to a class of drugs known as cholinesterase inhibitors, which work by increasing the levels of acetylcholine, a chemical messenger in the brain, to improve cognitive function, memory, and daily activities.

Composition of Rivastigmine 1.5 mg Capsule

• Active Ingredient: Rivastigmine 1.5 mg

• Brand Name: PYRITIGMIN RIVA 1.5

• Form: Capsule

• Category: Cholinesterase inhibitor

• Manufacturer: Steris Healthcare

Each capsule contains 1.5 mg of Rivastigmine, along with inactive excipients that help in capsule stability and absorption.

What is Rivastigmine 1.5 mg?

Rivastigmine 1.5 mg is a central nervous system (CNS) acting drug used to treat cognitive decline in patients with Alzheimers and Parkinsons disease dementia.

• It inhibits the enzyme acetylcholinesterase, which breaks down acetylcholine in the brain.

• By increasing acetylcholine levels, it enhances communication between nerve cells, improving memory, attention, and problem-solving skills.

• PYRITIGMIN RIVA 1.5 is suitable for patients who require a low starting dose, helping to minimize side effects during treatment initiation.

Uses of Rivastigmine 1.5 mg Capsules

1. Treatment of Mild to Moderate Alzheimers Disease

   • Improves cognitive function, memory, and daily activity performance.

2. Management of Parkinsons Disease Dementia

   • Helps in improving memory, attention, and behavioral symptoms.

3. Supportive Therapy for Cognitive Decline

   • Slows the progression of dementia-related symptoms.

Dosage and Administration

• Starting Dose: 1.5 mg capsule twice daily (morning and evening) or as prescribed by a doctor.

• Capsules should be swallowed whole with water, preferably after meals to reduce gastrointestinal side effects.

• Dose may be gradually increased based on tolerance and clinical response.

• Regular monitoring of weight, appetite, and cognitive function is recommended during therapy.